Background
Methods
Study design
Statistical analysis
Results
Group Variable | Group (P) (n = 30) | Group (E) (n = 30) | Group (D) (n = 30) | Group (D/E) (n = 30) |
P value |
---|---|---|---|---|---|
Age (years) | 46.50 ± 8.74 | 45.26 ± 7.50 | 48.36 ± 9.80 | 47.50 ± 10.14 | 0.455 |
Male/Female (n) | 15/15 | 17/13 | 18/12 | 16/14 | 0.471 |
Weight (kg) | 81.23 ± 13.24 | 82.53 ± 12.90 | 80.60 ± 13.37 | 78.83 ± 16.78 | 0.794 |
Height (cm) | 167.46 ± 8.50 | 165.53 ± 7.71 | 165.40 ± 8.21 | 165.00 ± 9.63 | 0.478 |
ASA (n) | |||||
I | 18 | 18 | 17 | 15 | 0.36 |
II | 7 | 6 | 9 | 10 | 0.42 |
III | 5 | 6 | 4 | 5 | 0.23 |
Duration of surgery (min) | 109.9 ± 10.8 | 115.7 ± 9.8 | 113.2 ± 13.7 | 117.8 ± 9.7 | 0.65 |
The morphine requirement
The pain score
Group Variable | Group (P) (n = 30) | Group (E) (n = 30) | Group (D) (n = 30) | Group (D/E) (n = 30) |
P value |
---|---|---|---|---|---|
At 0 h | 5 (4-5.25)bd
| 4 (3-4) acd
| 4 (3-5) bd
| 3 (3-4) abc
| 0.0001 |
At 2 h | 4 (3-5)bd | 3 (3-4) acd
| 4 (3-5) bd
| 3 (3-3)abc
| 0.0001 |
At 4 h | 4 (3-5) bd
| 3 (3-4) acd
| 3 (3-4) bd
| 2 (2-3)abc
| 0.0001 |
At 6 h | 3 (3-4) bd
| 3 (2-4) ad
| 2.5 (2-3)d
| 2 (1-3) abc
| 0.0001 |
At 12 h | 3 (3-3) bd
| 3 (2-3) ad
| 3 (2-3)d
| 2.5 (1-3) abc
| 0.0001 |
At 24 h | 3 (2-3) bcd
| 2(2-3) ad
| 2.5 (2-3) ad
| 2 (1-2)abc
| 0.0001 |
At 48 h | 3 (2-3) bcd
| 2 (2-3) ad
| 2 (2-3) ad
| 2 (0.75-2)abc
| 0.0001 |
Group Variable | Group (P) (n = 30) | Group (E) (n = 30) | Group (D) (n = 30) | Group (D/E) (n = 30) |
P value |
---|---|---|---|---|---|
0 h | 5 (5-6.25) d
| 5 (5-6) d
| 5 (5-6) d
| 5 (4.5.25) abc
| 0.013 |
After 2 h | 5 (5-6) d
| 5 (4-6) d
| 5 (5-6) d
| 5 (4-5) abc
| 0.002 |
After 4 h | 4 (4-5) d
| 4 (4-5) d
| 4 (4-5) d
| 4 (3-4) abc
| 0.019 |
After 6 h | 4 (3-5) d
| 4 (3-5) d
| 4 (4-5) d
| 4 (3-4) abc
| 0.007 |
After 12 h | 4 (3-5) d
| 4 (3-4) d
| 4 (3-4.25) d
| 3 (3-4) abc
| 0.030 |
After 24 h | 4 (3-5) d
| 4 (3-4.25) d
| 4 (3-4) d
| 3 (2.75-4) abc
| 0.059 |
After 48 h | 3.5 (3-4) d
| 3 (3-4) d
| 3.5 (3-4) d
| 3 (2.75-4) abc
| 0.049 |
Patients’ satisfaction
Group Patient satisfaction | Group(P) (n = 30) | Group(E) (n = 30) | Group(D) (n = 30) | Group(D/E) (n = 30) | p |
---|---|---|---|---|---|
ExEellent | 9 (30%) | 12(40%) | 11(36.7%) | 21 (63.3%)* | 0.004 |
Good | 9(30%) | 10(33.3%) | 9(30%) | 5(23.3%) | 0.237 |
Fair | 8(26.7%) | 5 (16.5%) | 6(20%) | 2(6.7%) | 0.069 |
Poor | 4(13.3%) | 3(10%) | 3(10%) | 2(6.7%) | 0.933 |
Group Side effect | Group(P) (n = 30) | Group(E) (n = 30) | Group(D) (n = 30) | Group(D/E) (n = 30) | p |
---|---|---|---|---|---|
PONV (%) IIII&IV | 13 (43.3%)* | 7 (23.3%) | 7 (23.3%) | 5 (16.6%) | 0.027 |
Somnolence | 1 (3.3%) | 1 (3.3%) | 2 (6.7%) | 3 (10%) | 0.225 |
Pruritus | 5 (16.7%) | 4 (13.3%) | 3 (10%) | 3 (10%) | 0.390 |
Dizziness | 1 (3.3%) | 2 (6.7%) | 4 (13.3%) | 3 (10%) | 0.239 |
Headache | 6 (20%) | 3 (10%) | 5 (16.7%) | 4 (13.3%) | 0.907 |